Assessment of dexmedetomidine and other agents for emesis induction in cats: 43 cases (2009–2014)

Vincent J. Thawley Section of Critical Care, Department of Clinical Studies-Philadelphia, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Search for other papers by Vincent J. Thawley in
Current site
Google Scholar
PubMed
Close
 VMD
and
Kenneth J. Drobatz Section of Critical Care, Department of Clinical Studies-Philadelphia, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Search for other papers by Kenneth J. Drobatz in
Current site
Google Scholar
PubMed
Close
 DVM, MSCE
Restricted access
Purchase Article

Abstract

Objective—To compare the use of dexmedetomidine hydrochloride, xylazine hydrochloride, and hydrogen peroxide for emesis induction in cats.

Design—Retrospective case series.

Animals—43 client-owned cats for which emesis induction was attempted because of known or suspected toxicant ingestion or recent ingestion of a string foreign body.

Procedures—Data collected from the cats’ medical records included type, dose, and route of administration of emetic agent; outcome of attempted emesis induction; time until emesis or postemesis administration of a reversal agent (to counter sedative effects of the emetic agent); and adverse events.

Results—Emesis induction was attempted by oral administration of hydrogen peroxide (n = 3) or IM or IV administration of xylazine (25 [including 1 cat that had already received hydrogen peroxide]) or dexmedetomidine (16). No cat that received hydrogen peroxide vomited. Emesis was induced in 11 of 25 xylazine-treated cats and in 13 of 16 dexmedetomidine-treated cats. Dexmedetomidine was more likely to cause vomiting than xylazine (OR, 5.5; 95% confidence interval, 1.1 to 36). The median dose of dexmedetomidine that caused emesis was 7. 0 μg/kg (3.2 μg/lb; range, 0.96 to 10.0 μg/kg [0.44 to 4.55 μg/lb]). The elapsed time until emesis or postemesis reversal agent administration was recorded for 5 xylazine-treated cats (median interval, 10 minutes [range, 5 to 175 minutes]) and 10 dexmedetomidine-treated cats (median interval, 5 minutes [range, 1 to 12 minutes]). Sedation was the only adverse effect, occurring in 2 xylazine-treated cats and 1 dexmedetomidine-treated cat.

Conclusions and Clinical Relevance—Results indicated that dexmedetomidine can be used successfully to induce emesis in cats.

All Time Past Year Past 30 Days
Abstract Views 1519 0 0
Full Text Views 7069 3220 199
PDF Downloads 5231 2245 133
Advertisement